Thermo Fisher Scientific’s centre to come up in Hyderabad soon

The newly expanded IEC is part of Thermo Fisher’s R&D Center of Excellence in India and will bring an additional 140 jobs to the region.

Published: 29th April 2022 05:20 AM  |   Last Updated: 29th April 2022 01:14 PM   |  A+A-

Thermo Fisher Scientific (Photo | twitter.com/thermofisher)

Thermo Fisher Scientific (Photo | twitter.com/thermofisher)

By Express News Service

HYDERABAD:  Hyderabad has become home to world-class manufacturing facilities and R&D centres. A few days after Ferring Pharmaceuticals opened its manufacturing facility, Thermo Fisher Scientific has now commissioned its India Engineering Centre (IEC).

The newly expanded IEC is part of Thermo Fisher’s R&D Center of Excellence in India and will bring an additional 140 jobs to the region. Thermo Fisher Scientific invests more than $1.4 billion annually in R&D. This IEC will employ over 450 diversely talented engineers and vendor partners. The centre at Hyderabad is a 42,000 sq ft facility that includes the engineering lab and will support new product development for laboratory and analytical solutions. 

At its inauguration, IT & Industries Minister KT Rama Rao said, “Inauguration of the IEC is a testament to the overall ecosystem for life sciences in Telangana and the pro-business policies of the Government, which attracts global players to Hyderabad. With the annual planned R&D investment of $15 million, I am also happy to learn that this facility will create employment of over 450 people, throughout the value chain.”

Thermo Fisher Scientific Asia Pacific president Tony Acciarito said: “Hyderabad is a hotspot for talent acquisition, home to world-renowned R&D institutes, and one of India’s fastest-growing engineering, life sciences, and IT knowledge hubs. The expansion of the facility is a testament to Thermo Fisher’s unwavering commitment to supporting change by accelerating innovation for new products.”

Thermo Fisher Scientific Inc is the world leader in serving science, with annual revenues of approximately $40 billion. Its global team delivers innovative technologies, purchasing convenience, and pharmaceutical services through industry-leading brands. 


India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.